» Articles » PMID: 20889166

The Montreal Cognitive Assessment (MoCA) is Superior to the Mini-Mental State Examination (MMSE) for the Detection of Vascular Cognitive Impairment After Acute Stroke

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2010 Oct 5
PMID 20889166
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The majority of patient with post-stroke Vascular Cognitive Impairment (VCI) have Vascular Cognitive Impairment No Dementia (VCIND). The Mini-Mental State Examination (MMSE) has been criticized as a poor screening test for VCIND due to insensitivity to visuospatial and executive function impairments. The Montreal Cognitive Assessment (MoCA) was designed to be more sensitive to such deficits and may therefore be a superior screening instrument for VCIND.

Methods: Stable patients within 14days of their index stroke without significant physical disability, aphasia, dysarthria, active psychiatric illness or pre-existing dementia were eligible. Cognitive and neurological measures were administered after informed consent.

Results: 100 patients were recruited. Of the 57 patients with unimpaired MMSE scores, 18 (32%) patients had an impaired MoCA score. By comparison, only 2 out of the 41 (4.9%) patients with unimpaired MoCA scores had impaired MMSE scores. Moreover, MMSE domain subtest scores could not differentiate between groups of differing screening test results, whilst MoCA domain subtest scores (Visuospatial/Executive Function, Attention and Recall) could.

Conclusion: The MoCA is more sensitive than the MMSE in screening for cognitive impairment after acute stroke. Longitudinal studies are required to establish the prognostic value of MoCA and MMSE evaluation in the acute post-stroke period for cognitive impairment as defined by the standard method of formal neuropsychological evaluation 3-6 months after stroke.

Citing Articles

Canadian Stroke Best Practice Recommendations: Vascular cognitive impairment, 7th edition practice guidelines update, 2024.

Swartz R, Longman R, Lindsay M, Lund R, Ganesh A, Eskes G Alzheimers Dement. 2025; 21(1):e14324.

PMID: 39822128 PMC: 11772713. DOI: 10.1002/alz.14324.


The effectiveness of non-invasive brain stimulation in treatment of major depressive disorder (MDD): a systematic review and transfer analysis.

Nejati V, Khorrami A, Vaziri Z, Shahri F, Yazdchi M, Abdolmanafi V J Neural Transm (Vienna). 2024; 132(3):369-385.

PMID: 39585445 DOI: 10.1007/s00702-024-02852-5.


Characterization and individual-level prediction of cognitive state in the first year after 'mild' stroke.

Saa J, Tse T, Koh G, Yap P, Baum C, Uribe-Rivera D PLoS One. 2024; 19(8):e0308103.

PMID: 39213374 PMC: 11364298. DOI: 10.1371/journal.pone.0308103.


The Montreal cognitive assessment: normative data from a large, population-based sample of Chinese healthy adults and validation for detecting vascular cognitive impairment.

Wei Q, Du B, Liu Y, Cao S, Yin S, Zhang Y Front Neurosci. 2024; 18:1455129.

PMID: 39145298 PMC: 11322342. DOI: 10.3389/fnins.2024.1455129.


Randomized Controlled Trial of Intradialytic Cognitive and Physical Training to Enhance Functional Capacity.

Bogataj S, Pajek M, Kren A, Kurnik Mesaric K, Pajek J Kidney Int Rep. 2024; 9(7):2028-2036.

PMID: 39081752 PMC: 11284388. DOI: 10.1016/j.ekir.2024.04.029.